The alternative complement pathway in ANCA-associated vasculitis: further evidence and a meta-analysis

Area of Science:

• Immunology
• Rheumatology

Background:

• ANCA-associated vasculitis (AAV) is a severe autoimmune disease.
• The role of complement system activation in AAV pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate complement pathway component levels in AAV patients.
• To determine the association between complement activation and disease activity.
• To meta-analyze existing clinical evidence on complement's role in AAV.

Main Methods:

• Compared complement components (C3a, C5a, MAC, factor B, properdin) in 59 AAV patients and 36 healthy controls.
• Re-evaluated complement levels in 28 patients upon achieving remission.
• Conducted a meta-analysis of five relevant studies, including the current one.

Main Results:

• Active AAV patients showed significantly higher median concentrations of MAC, C5a, C3a, and factor B compared to controls.
• Remission in AAV was associated with reduced levels of C3a, C5a, and factor B.
• Meta-analysis confirmed increased plasma MAC, C5a, and factor B in active AAV versus remission and controls.

Conclusions:

• Findings support a predominant role for alternative complement pathway activation in AAV.
• Complement activation markers may serve as indicators of disease activity in AAV.